Company / R&D Expense
Jaguar Health, Inc. R&D Expense History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$16.5M
FY2025
5-year range
$5.2M / $18.6M
FY2021-FY2025
Trend
-11.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has fluctuated over the past 9 years, ranging from $4M in FY2015 to $19M in FY2024.
Based on SEC 10-K filings.
$17M in FY2025 with a 10-year CAGR of +14.6%.
Improved from $15M to $17M over the past 3 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +3.1%
- 5-Year CAGR
- +23.2%
- 10-Year CAGR
- +14.6%
Key checks
Key Insights
- 5-year CAGR of +23.2%, indicating consistent growth.
- In FY2025, r&d expense decreased 11.0% year-over-year.
- Peak r&d expense was recorded in FY2024.
- Lowest r&d expense in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.5M | -11.0% |
| FY2024 | $18.6M | +23.3% |
| FY2022 | $15.1M | +159.1% |
| FY2020 | $5.8M | +12.9% |
| FY2019 | $5.2M | +20.7% |
| FY2018 | $4.3M | -40.8% |
| FY2017 | $7.2M | +11.3% |
| FY2016 | $6.5M | +53.4% |
| FY2015 | $4.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026